A treatment use protocol of entecavir in subjects with chronic hepatitis B infection who have failed or who are intolerant of available therapies

Trial Profile

A treatment use protocol of entecavir in subjects with chronic hepatitis B infection who have failed or who are intolerant of available therapies

Recruiting
Phase of Trial: Phase III

Latest Information Update: 23 Sep 2016

At a glance

  • Drugs Entecavir (Primary)
  • Indications Hepatitis B
  • Focus Expanded access; Therapeutic Use
  • Most Recent Events

    • 14 Jul 2008 The expected completion date for this trial has been extended from Jun 2008 to 1 Aug 2008, as reported by Clinicaltrials.gov.
    • 24 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top